Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Prostatic Neoplasms 163Breast Neoplasms 123Lung Neoplasms 101Carcinoma, Non-Small-Cell Lung 83Glioblastoma 77Brain Neoplasms 74Neoplasm Metastasis 68Glioma 68Pancreatic Neoplasms 50Neoplasms 45Carcinoma, Renal Cell 45Multiple Myeloma 44Colorectal Neoplasms 43Squamous Cell Carcinoma of Head and Neck 39Lymphoma, Large B-Cell, Diffuse 39Carcinoma, Hepatocellular 36Ovarian Neoplasms 34Melanoma 34Lymphoma 34Urinary Bladder Neoplasms 33Astrocytoma 30Sarcoma 26Rectal Neoplasms 26Uterine Cervical Neoplasms 24Oropharyngeal Neoplasms 24Lymphoma, Follicular 24Central Nervous System Neoplasms 24Lymphoma, Non-Hodgkin 23Triple Negative Breast Neoplasms 22Gliosarcoma 22

Interventions

relacorilant 3Mifepristone 3Corlux 3Cabergoline 3pasireotide 2fimepinostat 1corticorelin ovine 1Tissue Banks 1Rosiglitazone 1Perceived Stress Scale 1Magnetic Resonance Spectroscopy 1Deamino Arginine Vasopressin 1Biomarkers 14-amino-4'-hydroxylaminodiphenylsulfone 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pituitary ACTH Hypersecretion × Magnetic Resonance Spectroscopy × Clear all
NCT03474601 2020-03-18

SNU-PIT

Seoul National University Hospital

Unknown
1,600 enrolled
Endocrine

Acromegaly, Pituitary Diseases, Pituitary Neoplasms, Prolactinoma, Diabetes Insipidus, Neurogenic, Pituitary ACTH Hypersecretion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡